First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy

Kidney Int. 2023 Apr;103(4):669-673. doi: 10.1016/j.kint.2022.05.034.

Authors

Chee Kay Cheung¹, Jonathan Barratt²

Affiliations

¹ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.
² Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK. Electronic address: jb81@le.ac.uk.

PMID: 36948769
DOI: 10.1016/j.kint.2022.05.034

No abstract available

MeSH terms

Glomerulonephritis, IGA* / drug therapy
Glucocorticoids* / adverse effects
Humans
Immunosuppressive Agents
Kidney

Substances

Glucocorticoids
Immunosuppressive Agents